Quantification of serum and cerebrospinal fluid gelsolin in familial amyloidosis, Finnish type (AGel)

References

• Meretoja J. Familial systemic paramyloidosis with lattice dystrophy of the cornea, progressive cranial neuropathy, skin changes and various internal symptoms. A previously unrecognized heritable syndrome. Ann Clin Res 1969; 1: 314–324
   PubMedGoogle Scholar
• Meretoja J. Genetic aspects of familial amyloidosis with corneal lattice dystrophy and cranial neuropathy. Clin Genet 1973; 4: 173–185
   PubMed Web of Science ®Google Scholar
• Meretoja J. Histopathological findings of familial amyloidosis with cranial neuropathy as principal manifestation. Acta Path Microbiol Scand Section A 1971; 79: 432–440
   PubMedGoogle Scholar
• Maury C PJ, Alii K, Bauman M. Finnish hereditary amyloidosis. Amino acid sequence homology between the amyloid fibril protein and human plasma gelsolin. FEBS Letters. 1990; 260: 85–87
   PubMed Web of Science ®Google Scholar
• Haltia M, Prelli F, Ghiso J, Kiuru S, Somer H, Palo J, Frangione B. Amyloid protein in familial amyloidosis (Finnish type) is homologous to gelsolin, an actin-binding protein. Biochem Biophys Res Comm 1990; 167: 927–932
   PubMed Web of Science ®Google Scholar
• Yin H, Kwiatkowski D J, Mole J E, Cole F C. Structure and biosynthesis of cytoplasmic and secreted variants of gelsolin. J Biol Chem 1984; 259: 5271–5276
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Mehl R, Yin H L. Genomic organization and biosynthesis of secreted and cytoplasmic forms of gelsolin. J Cell Biol 1988; 106: 375–384
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Stossel T P, Orkin S H, Mole J E, Colten H R, Yin H L. Plasma and cytoplasmic gelsolins are encoded by a single gene and contain a duplicated actin-binding domain. Nature 1986; 323: 455–458
   PubMed Web of Science ®Google Scholar
• Kwiatkowski D J, Mehl R, Izumo S, Nadal-Ginard B, Yin H L. Muscle is the major source of plasma gelsolin. J Biol Chem 1988; 263: 8239–8243
   PubMedGoogle Scholar
• Levy E, Haltia M, Fernandez-Madrid I, Koivunen O, Ghiso J, Prelli F, Frangione B. Mutation in gelsolin gene in Finnish hereditary amyloidosis. J Exp Med 1990; 172: 1865–1867
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Kere J, Tolvanen R, de la Chapelle A. Finnish hereditary amyloidosis is caused by a single nucleotide substitution in the gelsolin gene. FEBS Letters 1990; 276: 75–77
   PubMed Web of Science ®Google Scholar
• Paunio T, Kiuru S, Hongell V, Mustonen E, Syvänen A C, Bengtstöm M, Palo J, Peltonen L. Solid-phase minisequencing test reveals Asp187Asn (G654A) mutation of gelsolin in all affected individuals with Finnish type of familial amyloidosis. Genomics 1992; 12: 237–239
   Google Scholar
• De la Chapelle A, Tolvanen R, Boysen G, Santavy J, Bleeker-Wagemakers L, Maury C PJ, Kere J. Gelsolin-derived familial amyloidosis caused by aspar-agine or tyrosine substitution for aspartic acid at residue 187. Nature Genetics 1992; 2: 157–160
   PubMed Web of Science ®Google Scholar
• De la Chapelle A, Kere J, Sack G J, Jr, Tolvanen R, Maury C PJ. Familial amyloidosis, Finnish type: G654A mutation of the gelsolin gene in Finnish families and an unrelated American family. Genomics 1992; 13: 898–901
   PubMed Web of Science ®Google Scholar
• Gorevic P, Munoz Z, Gorgone G, Purcell J J, Jr, Rodrigues M, Ghiso J, Levy E, Haltia M, Frangione B. Amyloidosis due to a mutation of the gelsolin gene in an American family with lattice corneal dystrophy type II. New EnglJ Med 1991; 325: 1780–1785
   PubMed Web of Science ®Google Scholar
• Sunada Y, Schimizu Y, Nakase H, Ohta S, Asaoka T, Amano S, Sawa M, Kagawa Y, Kanazawa I, Mannen T. Inherited amyloid polyneuropathy type-IV (gelsolin variant) in a Japanese family. Ann Neurology 1993; 33: 57–62
   PubMed Web of Science ®Google Scholar
• Haltia M, Levy E, Meretoja J, Fernandez-Madrid I, Koivunen O, Frangione B. Gelsolin gene mutation - at codon 187 - in familial amyloidosis, Finnish: a DNA-diagnostic assay. Am J Med Gen 1992; 42: 357–359
   PubMed Web of Science ®Google Scholar
• Maury C PJ, Nurmiaho-Lassila E L. Creation of amyloid fibrils from mutant Asn 187 gelsolin peptides. Biochem Biophys Res Comm 1992; 183: 227–231
   PubMed Web of Science ®Google Scholar
• Van Nostrand W E, Wagner S L, Haan J, Bakker E, Roos R AC. Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid β-protein precursor. Ann Neurol. 1992; 32: 215–218
   PubMed Web of Science ®Google Scholar
• Farlow M, Ghetti B, Benson M D, Farrow J S, Nostrand W E, Wagner S L. Low cerebrospinal concentrations of soluble amyloid β-protein precursor in hereditary Alzheimer's disease. Lancet 1992; 340: 453–454
   PubMed Web of Science ®Google Scholar
• Ueno S, Fujimara H, Yorifuji S, Nakamura Y, Takahashi M, Seiichiro T, et al. Familial amyloid polyneuropathy associated with the transthyretin Cysl 14 gene in a Japanese kindred. Brain 1992; 115: 1275–1289
   PubMed Web of Science ®Google Scholar
• Benson M D, Dwulet F E. Prealbumin and retinol binding protein serum concentrations in the Indiana type hereditary amyloidosis. Arthritis Rheum 1983; 26: 1493–1498
   PubMed Web of Science ®Google Scholar
• Saraiva M JM, Costa P P, Goodman D S. Studies on plasma transthyretin (prealbumin) in familial amyloidotic polyneuropathy, Portuguese type. J Lab Clin Med 1983; 102: 590–603
   PubMed Web of Science ®Google Scholar
• Shoji S, Nakagawa S. Serum prealbumin and re-tinol-binding protein concentrations in Japanese-type familial amyloid polyneuropathy. Eur Neurol 1988; 28: 191–193
   PubMedGoogle Scholar
• Edelstein C, Scanu A. Precautionary measures for collecting blood destined for lipoprotein isolation. Methods in Enzymology, J P Segrest, J J Albers. Academic Press, New York 1986; vol 128: 151–155
   Google Scholar
• Tarentino A L, Gomez C M, Plummer T H, Jr. Deglycosylation of asparagine-linked glycans by peptide: N-glycosidase F. Biochemistry 1985; 24: 4665–4671
   PubMed Web of Science ®Google Scholar
• Chaponnier C, Janmey P A, Yin H L. The actin filament-severing domain of plasma gelsolin. J Cell Biol 1986; 103: 1475–1481
   Google Scholar
• Maury C PJ. Isolation and characterization of cardiac amyloid in familial amyloid polyneuropathy type IV (Finnish): relation of the amyloid protein to variant gelsolin. Biochim Biophys Acta 1990; 1096: 84–86, 1990
   PubMed Web of Science ®Google Scholar
• Green N, Alexander H, Olson A, Alexander S, Shinnick T M, Sutcliffe J G, Lerner R A. Immunogenic structure of the influenza virus hemagglutinin. Cell 1982; 477–487
   Google Scholar
• Kurokawa H, Fuji W, Ohmi K, Sakurai T, Nonomura Y. Simple and rapid purification of brevin. Biochem Biophys Res Comm 1990; 168: 451–457
   Google Scholar
• Sakurai T, Ohmi K, Kurokawa H, Nonomura Y. Distribution of a gelsolin-like 74,000 mol wt protein in neural and endocrine tissues. Neuroscience 1990; 38: 743–756
   Google Scholar
• Karonen S L, Holmberg H, Lahteenmaki P, Adlecreutz H. Studies on the determination of plasma prolactin. Scand J Clin Lab Invest 1978; 38: 249–254
   PubMedGoogle Scholar
• Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–254
   PubMed Web of Science ®Google Scholar
• Siegel S, Castellan N J. Non-parametric statistics for the behavioural sciencesEd 2. McGraw-Hill, New York 1988; 128–139
   Google Scholar
• Towbin H, Staehlin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci 1979; 76: 4350–4353
   PubMed Web of Science ®Google Scholar
• Smith D B, Janmey P A, Herbert T J, Lind S E. Quantitive measurement of plasma gelsolin and its incorporation into fibrin clots. J Lab Clin Med 1987; 110: 189–195
   Google Scholar
• Tawara S, Nakazo M, Kangawa K, Hisayuki M, Shukuro A. Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 1983; 116: 880–888
   PubMed Web of Science ®Google Scholar
• Westermark P, Pitkanen P, Benson L, Vahlquist A, Olofsson B O, Cornwell G G. Serum prealbumin and retinol-binding protein in the prealbumin-related senile and familial forms of systemic amyloidosis. Lab Investigation 1985; 52: 314–318
   PubMed Web of Science ®Google Scholar
• Kiuru S. Familial amyloidosis of the Finnish type (FAF). A clinical study of 30 patients. Acta Neurol Scand 1992; 86: 346–353
   PubMed Web of Science ®Google Scholar
• Van Nostrand W E, Wagner S L, Shankle W R, et al. Decreased levels of soluble amyloid β-protein precursor in cerebrospinal fluid of live Alzheimer disease patients. Proc Natl Acad Sci 1992; 89: 2551–2555
   PubMed Web of Science ®Google Scholar
• Grubb A, Jensson O, Gudmundsson G, Arnason A, Löfberg H, Malm J. Abnormal metabolism of γ-trace alkaline microprotein. The basic defect in hereditary cerebral hemorrhage with amyloidosis. New Engl J Med 1984; 311: 1547–1549
   PubMed Web of Science ®Google Scholar
• Olafsson I, Gudmundsson G, Abrahamson M, Jensson O, Grubb A. The amino terminal portion of cerebrospinal fluid cystatin C in hereditary cystatin C amyloid angiopathy is not truncated: direct sequence analysis from agarose gel electropherograms. Scand J Lab Invest 1990; 50: 85–93
   PubMedGoogle Scholar
• Fishman R A. Chapter 7. Cerebrospinal findings in diseases of the nervous system. Saunders, Philadelphia 1980; 253–325
   Google Scholar
• Maury C PJ, Rossi H. Demonstration of a circulating 65K gelsolin variant specific for familial amyloidosis, Finnish type. Biochem Biophys Res Comm 1993; 191: 41–44
   PubMed Web of Science ®Google Scholar